New hope for vulnerable patients: study tests stronger COVID treatments
NCT ID NCT07406217
Summary
This study aims to find better COVID-19 treatments for people with weakened immune systems. Researchers are testing whether combining two antiviral drugs works better than using one alone, and whether extending treatment from 5 to 10 days helps clear the virus faster. The trial will include 256 immunocompromised participants across several European countries.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for COVID-19 are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Basel University Hospital
RECRUITINGBasel, Basel, 4031, Switzerland
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
CHUV
RECRUITINGLausanne, Canton of Vaud, 10-549, Switzerland
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Hôpitaux Universitaires de Genève
RECRUITINGGeneva, Canton of Geneva, 1205, Switzerland
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
University Hospital Zurich
RECRUITINGZurich, Canton of Zurich, 8091, Switzerland
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.